• UroGen Pharma (NASDAQ:URGN) Receives Buy Rating from HC Wainwright

    Источник: Buzz FX / 25 фев 2025 07:11:19   America/Chicago


    UroGen Pharma (NASDAQ:URGN) Receives Buy Rating from HC Wainwright Written by MarketBeat February 25, 2025 Share Link copied to clipboard. UroGen Pharma ( NASDAQ:URGN - Get Free Report ) 's stock had its "buy" rating reiterated by investmen
    Read more...
Опубликовать